

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.00058545 |
| 2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.00058545 |
| 3 | Golgi transport vesicle coating (GO:0048200) | 3.77881288 |
| 4 | COPI coating of Golgi vesicle (GO:0048205) | 3.77881288 |
| 5 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.76739254 |
| 6 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.63657727 |
| 7 | protein maturation by protein folding (GO:0022417) | 3.30846556 |
| 8 | neutrophil activation involved in immune response (GO:0002283) | 3.25248112 |
| 9 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.22564372 |
| 10 | detection of other organism (GO:0098543) | 2.98420580 |
| 11 | fibril organization (GO:0097435) | 2.80418272 |
| 12 | negative regulation of cell killing (GO:0031342) | 2.78020209 |
| 13 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.78020209 |
| 14 | phagocytosis, engulfment (GO:0006911) | 2.77991959 |
| 15 | extracellular fibril organization (GO:0043206) | 2.72941892 |
| 16 | detection of bacterium (GO:0016045) | 2.72210907 |
| 17 | regulation of early endosome to late endosome transport (GO:2000641) | 2.71614438 |
| 18 | response to laminar fluid shear stress (GO:0034616) | 2.68485482 |
| 19 | peptide catabolic process (GO:0043171) | 2.67986364 |
| 20 | hypotonic response (GO:0006971) | 2.66227763 |
| 21 | regulation of protein heterodimerization activity (GO:0043497) | 2.65649309 |
| 22 | positive regulation of lamellipodium assembly (GO:0010592) | 2.65245537 |
| 23 | leukocyte aggregation (GO:0070486) | 2.63506659 |
| 24 | sequestering of metal ion (GO:0051238) | 2.62719325 |
| 25 | membrane raft organization (GO:0031579) | 2.61528777 |
| 26 | regulation of superoxide anion generation (GO:0032928) | 2.61126119 |
| 27 | cell adhesion mediated by integrin (GO:0033627) | 2.56266741 |
| 28 | actin nucleation (GO:0045010) | 2.56111099 |
| 29 | morphogenesis of an endothelium (GO:0003159) | 2.54123619 |
| 30 | endothelial tube morphogenesis (GO:0061154) | 2.54123619 |
| 31 | pinocytosis (GO:0006907) | 2.53423777 |
| 32 | response to host (GO:0075136) | 2.53421797 |
| 33 | response to host defenses (GO:0052200) | 2.53421797 |
| 34 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.53421797 |
| 35 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.52455740 |
| 36 | regulation of mast cell degranulation (GO:0043304) | 2.51660847 |
| 37 | regulation of leukocyte degranulation (GO:0043300) | 2.51469917 |
| 38 | immunoglobulin mediated immune response (GO:0016064) | 2.50966434 |
| 39 | apoptotic cell clearance (GO:0043277) | 2.50725268 |
| 40 | positive regulation of receptor recycling (GO:0001921) | 2.50529981 |
| 41 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.50076212 |
| 42 | regulation of macrophage cytokine production (GO:0010935) | 2.49974909 |
| 43 | detection of external biotic stimulus (GO:0098581) | 2.49949211 |
| 44 | response to host immune response (GO:0052572) | 2.49791360 |
| 45 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.49791360 |
| 46 | * stress fiber assembly (GO:0043149) | 2.47221479 |
| 47 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.47088731 |
| 48 | detection of molecule of bacterial origin (GO:0032490) | 2.46168060 |
| 49 | positive regulation of leukocyte degranulation (GO:0043302) | 2.45903005 |
| 50 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.42597750 |
| 51 | macrophage activation involved in immune response (GO:0002281) | 2.42545205 |
| 52 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.41664108 |
| 53 | myeloid cell homeostasis (GO:0002262) | 2.40502917 |
| 54 | hyaluronan catabolic process (GO:0030214) | 2.38660691 |
| 55 | wound healing, spreading of epidermal cells (GO:0035313) | 2.37521836 |
| 56 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.36157972 |
| 57 | establishment of endothelial barrier (GO:0061028) | 2.36143834 |
| 58 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.35757997 |
| 59 | positive regulation by symbiont of host defense response (GO:0052509) | 2.35039050 |
| 60 | modulation by symbiont of host defense response (GO:0052031) | 2.35039050 |
| 61 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.35039050 |
| 62 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.35039050 |
| 63 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.35039050 |
| 64 | modulation by symbiont of host immune response (GO:0052553) | 2.35039050 |
| 65 | basement membrane organization (GO:0071711) | 2.34590294 |
| 66 | positive regulation of macrophage differentiation (GO:0045651) | 2.34468107 |
| 67 | detection of biotic stimulus (GO:0009595) | 2.34101571 |
| 68 | wound healing, spreading of cells (GO:0044319) | 2.31639861 |
| 69 | glycosphingolipid catabolic process (GO:0046479) | 2.30917442 |
| 70 | negative regulation of phagocytosis (GO:0050765) | 2.30093597 |
| 71 | positive regulation of interferon-alpha production (GO:0032727) | 2.28716029 |
| 72 | establishment of integrated proviral latency (GO:0075713) | 2.28312523 |
| 73 | neutrophil activation (GO:0042119) | 2.27852973 |
| 74 | membrane invagination (GO:0010324) | 2.27777377 |
| 75 | hepatocyte apoptotic process (GO:0097284) | 2.27647297 |
| 76 | low-density lipoprotein particle clearance (GO:0034383) | 2.27128382 |
| 77 | pentose-phosphate shunt (GO:0006098) | 2.26601319 |
| 78 | response to thyroid hormone (GO:0097066) | 2.26408543 |
| 79 | T cell apoptotic process (GO:0070231) | 2.26225788 |
| 80 | positive regulation of macrophage cytokine production (GO:0060907) | 2.26020214 |
| 81 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.25023454 |
| 82 | B cell mediated immunity (GO:0019724) | 2.24840073 |
| 83 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.23993357 |
| 84 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.23664396 |
| 85 | signal peptide processing (GO:0006465) | 2.23642792 |
| 86 | regulation of SMAD protein import into nucleus (GO:0060390) | 2.23313237 |
| 87 | endodermal cell differentiation (GO:0035987) | 2.23092136 |
| 88 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.22858395 |
| 89 | leukocyte cell-cell adhesion (GO:0007159) | 2.22439951 |
| 90 | establishment of viral latency (GO:0019043) | 2.22101891 |
| 91 | NIK/NF-kappaB signaling (GO:0038061) | 2.20981947 |
| 92 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.19153602 |
| 93 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.19110789 |
| 94 | regulation of interferon-alpha production (GO:0032647) | 2.19092077 |
| 95 | lymphocyte apoptotic process (GO:0070227) | 2.18945036 |
| 96 | myeloid cell activation involved in immune response (GO:0002275) | 2.18275890 |
| 97 | regulation of defense response to virus by virus (GO:0050690) | 2.18255154 |
| 98 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.18121686 |
| 99 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.17624906 |
| 100 | protein retention in ER lumen (GO:0006621) | 2.17428869 |
| 101 | keratan sulfate catabolic process (GO:0042340) | 2.17423566 |
| 102 | positive regulation of mast cell activation (GO:0033005) | 2.16487489 |
| 103 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.16146343 |
| 104 | negative regulation of interleukin-17 production (GO:0032700) | 2.15661719 |
| 105 | skin morphogenesis (GO:0043589) | 2.15022756 |
| 106 | positive regulation of lamellipodium organization (GO:1902745) | 2.14874030 |
| 107 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.14746364 |
| 108 | granulocyte activation (GO:0036230) | 2.14331148 |
| 109 | protein localization to endosome (GO:0036010) | 2.14213762 |
| 110 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.14020153 |
| 111 | positive regulation of B cell differentiation (GO:0045579) | 2.13750048 |
| 112 | regulation of monocyte chemotaxis (GO:0090025) | 2.12749132 |
| 113 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.12405489 |
| 114 | NADPH regeneration (GO:0006740) | 2.11584871 |
| 115 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.10899772 |
| 116 | regulation of tolerance induction (GO:0002643) | 2.10899056 |
| 117 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.09589114 |
| 118 | respiratory burst (GO:0045730) | 2.09225794 |
| 119 | angiogenesis involved in wound healing (GO:0060055) | 2.07406642 |
| 120 | integrin-mediated signaling pathway (GO:0007229) | 2.07025388 |
| 121 | renal filtration (GO:0097205) | 2.06454362 |
| 122 | response to peptidoglycan (GO:0032494) | 2.05792224 |
| 123 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.05403966 |
| 124 | platelet aggregation (GO:0070527) | 2.04193190 |
| 125 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.03788259 |
| 126 | regulation of metalloenzyme activity (GO:0048552) | 2.03298633 |
| 127 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.02936053 |
| 128 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 2.02470280 |
| 129 | cortical actin cytoskeleton organization (GO:0030866) | 2.02034622 |
| 130 | glomerular filtration (GO:0003094) | 1.98127313 |
| 131 | localization within membrane (GO:0051668) | 1.97452768 |
| 132 | positive regulation of nuclease activity (GO:0032075) | 1.97444339 |
| 133 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 1.96079187 |
| 134 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 1.95872551 |
| 135 | response to muramyl dipeptide (GO:0032495) | 1.94855407 |
| 136 | cellular response to zinc ion (GO:0071294) | 1.94547881 |
| 137 | growth hormone receptor signaling pathway (GO:0060396) | 1.93698483 |
| 138 | apoptotic process involved in morphogenesis (GO:0060561) | 1.92758106 |
| 139 | regulation of gamma-delta T cell differentiation (GO:0045586) | 1.92573020 |
| 140 | negative regulation of interleukin-12 production (GO:0032695) | 1.92474406 |
| 141 | regulation of B cell differentiation (GO:0045577) | 1.92362570 |
| 142 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 1.92269527 |
| 143 | leukocyte apoptotic process (GO:0071887) | 1.91407735 |
| 144 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 1.91165230 |
| 145 | cellular response to interferon-alpha (GO:0035457) | 1.90325827 |
| 146 | cellular extravasation (GO:0045123) | 1.89610332 |
| 147 | barbed-end actin filament capping (GO:0051016) | 1.89411415 |
| 148 | mesodermal cell differentiation (GO:0048333) | 1.89222258 |
| 149 | substrate adhesion-dependent cell spreading (GO:0034446) | 1.89074482 |
| 150 | negative regulation of interleukin-8 production (GO:0032717) | 1.88761701 |
| 151 | regulation of nuclease activity (GO:0032069) | 1.87858737 |
| 152 | COPII vesicle coating (GO:0048208) | 1.87339430 |
| 153 | negative regulation of erythrocyte differentiation (GO:0045647) | 1.87334662 |
| 154 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 1.86817310 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.05881112 |
| 2 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.43562261 |
| 3 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.07406728 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.80491604 |
| 5 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.76511220 |
| 6 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.68732487 |
| 7 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.50462921 |
| 8 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.30714971 |
| 9 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.26977939 |
| 10 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.21792698 |
| 11 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.16388060 |
| 12 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.15375314 |
| 13 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.14669680 |
| 14 | MYC_22102868_ChIP-Seq_BL_Human | 2.13024185 |
| 15 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.04320268 |
| 16 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.02646927 |
| 17 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.98754446 |
| 18 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.97809523 |
| 19 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.97014301 |
| 20 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.91924221 |
| 21 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.90017336 |
| 22 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.84337510 |
| 23 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.83693566 |
| 24 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.82520585 |
| 25 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.81063979 |
| 26 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.78991844 |
| 27 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.75901131 |
| 28 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.70479044 |
| 29 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.68387462 |
| 30 | MAF_26560356_Chip-Seq_TH1_Human | 1.67318811 |
| 31 | MYB_26560356_Chip-Seq_TH2_Human | 1.66779108 |
| 32 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.66245219 |
| 33 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.59588648 |
| 34 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.55778875 |
| 35 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.55689687 |
| 36 | * SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.51361968 |
| 37 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.50536835 |
| 38 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.47906194 |
| 39 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.47757210 |
| 40 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.46198299 |
| 41 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.42359965 |
| 42 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.41153956 |
| 43 | MYB_26560356_Chip-Seq_TH1_Human | 1.40773054 |
| 44 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.40684569 |
| 45 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.39927788 |
| 46 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.39325852 |
| 47 | UTX_26944678_Chip-Seq_JUKART_Human | 1.38248266 |
| 48 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.37842024 |
| 49 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.36276659 |
| 50 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.36127523 |
| 51 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.34906293 |
| 52 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.34519060 |
| 53 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.32459512 |
| 54 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.32012519 |
| 55 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.31598176 |
| 56 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.30764213 |
| 57 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.28172155 |
| 58 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.27847440 |
| 59 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.25220477 |
| 60 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.24099495 |
| 61 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.23634591 |
| 62 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.22345559 |
| 63 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21809950 |
| 64 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.21071119 |
| 65 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.20988446 |
| 66 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.19114751 |
| 67 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.18403778 |
| 68 | GATA1_22025678_ChIP-Seq_K562_Human | 1.18355205 |
| 69 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.18292203 |
| 70 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.18091014 |
| 71 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.16648384 |
| 72 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.16629749 |
| 73 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.13301940 |
| 74 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.12014383 |
| 75 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.12014383 |
| 76 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.11634754 |
| 77 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.11374246 |
| 78 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11312221 |
| 79 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.11158890 |
| 80 | SPI1_23127762_ChIP-Seq_K562_Human | 1.10391940 |
| 81 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.10050099 |
| 82 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.09585960 |
| 83 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.09017687 |
| 84 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.08989303 |
| 85 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.07933112 |
| 86 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.07577716 |
| 87 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.07416961 |
| 88 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.05572626 |
| 89 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.05158166 |
| 90 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.03764128 |
| 91 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.03662015 |
| 92 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.03426393 |
| 93 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.03210689 |
| 94 | * TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.02373265 |
| 95 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.01580946 |
| 96 | ATF3_27146783_Chip-Seq_COLON_Human | 1.01495745 |
| 97 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.01202423 |
| 98 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.00613467 |
| 99 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.00273811 |
| 100 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.99984803 |
| 101 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.99983921 |
| 102 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.99758775 |
| 103 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.99287135 |
| 104 | * MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.99102497 |
| 105 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.99077175 |
| 106 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.98777677 |
| 107 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.98472762 |
| 108 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 0.98410959 |
| 109 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.98379476 |
| 110 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.97528582 |
| 111 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.97507611 |
| 112 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.97207241 |
| 113 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.97125372 |
| 114 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.97015248 |
| 115 | * EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.96987899 |
| 116 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.96967845 |
| 117 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.96249474 |
| 118 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.95339460 |
| 119 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.94976972 |
| 120 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 0.94636245 |
| 121 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.94600277 |
| 122 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.93700916 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008438_abnormal_cutaneous_collagen | 3.20703490 |
| 2 | MP0006054_spinal_hemorrhage | 2.49620141 |
| 3 | MP0003705_abnormal_hypodermis_morpholog | 2.23402314 |
| 4 | MP0003566_abnormal_cell_adhesion | 2.13279152 |
| 5 | MP0001835_abnormal_antigen_presentation | 2.12320094 |
| 6 | MP0010352_gastrointestinal_tract_polyps | 2.07018912 |
| 7 | MP0003300_gastrointestinal_ulcer | 2.03494738 |
| 8 | MP0008260_abnormal_autophagy | 2.03071813 |
| 9 | MP0003436_decreased_susceptibility_to | 1.97222762 |
| 10 | MP0003303_peritoneal_inflammation | 1.85698391 |
| 11 | MP0005058_abnormal_lysosome_morphology | 1.84880436 |
| 12 | MP0005275_abnormal_skin_tensile | 1.84586630 |
| 13 | MP0003279_aneurysm | 1.82675629 |
| 14 | MP0000685_abnormal_immune_system | 1.79428548 |
| 15 | MP0001958_emphysema | 1.67847688 |
| 16 | MP0005023_abnormal_wound_healing | 1.61188524 |
| 17 | MP0003724_increased_susceptibility_to | 1.57468849 |
| 18 | MP0005000_abnormal_immune_tolerance | 1.56769742 |
| 19 | MP0002877_abnormal_melanocyte_morpholog | 1.53586328 |
| 20 | MP0004272_abnormal_basement_membrane | 1.52134396 |
| 21 | MP0002419_abnormal_innate_immunity | 1.52047805 |
| 22 | MP0005387_immune_system_phenotype | 1.51737354 |
| 23 | MP0001790_abnormal_immune_system | 1.51737354 |
| 24 | MP0002166_altered_tumor_susceptibility | 1.49520480 |
| 25 | MP0001533_abnormal_skeleton_physiology | 1.49447769 |
| 26 | MP0002933_joint_inflammation | 1.47041985 |
| 27 | MP0009333_abnormal_splenocyte_physiolog | 1.46783503 |
| 28 | MP0009278_abnormal_bone_marrow | 1.46772708 |
| 29 | MP0002452_abnormal_antigen_presenting | 1.46709915 |
| 30 | MP0009785_altered_susceptibility_to | 1.46337932 |
| 31 | MP0002396_abnormal_hematopoietic_system | 1.43736850 |
| 32 | MP0003075_altered_response_to | 1.43144763 |
| 33 | MP0003448_altered_tumor_morphology | 1.40811903 |
| 34 | MP0005025_abnormal_response_to | 1.38754863 |
| 35 | MP0004947_skin_inflammation | 1.37805569 |
| 36 | MP0002148_abnormal_hypersensitivity_rea | 1.36804890 |
| 37 | MP0000858_altered_metastatic_potential | 1.35814346 |
| 38 | MP0002405_respiratory_system_inflammati | 1.35640350 |
| 39 | MP0005076_abnormal_cell_differentiation | 1.34665358 |
| 40 | MP0001800_abnormal_humoral_immune | 1.34258339 |
| 41 | MP0005671_abnormal_response_to | 1.32407681 |
| 42 | MP0002420_abnormal_adaptive_immunity | 1.31965705 |
| 43 | MP0001819_abnormal_immune_cell | 1.30919736 |
| 44 | MP0000465_gastrointestinal_hemorrhage | 1.30692139 |
| 45 | MP0003806_abnormal_nucleotide_metabolis | 1.30554513 |
| 46 | MP0003172_abnormal_lysosome_physiology | 1.28874345 |
| 47 | MP0000343_altered_response_to | 1.27538142 |
| 48 | MP0002723_abnormal_immune_serum | 1.26571363 |
| 49 | MP0001879_abnormal_lymphatic_vessel | 1.25790617 |
| 50 | MP0010234_abnormal_vibrissa_follicle | 1.22602275 |
| 51 | MP0005397_hematopoietic_system_phenotyp | 1.22132048 |
| 52 | MP0001545_abnormal_hematopoietic_system | 1.22132048 |
| 53 | MP0006082_CNS_inflammation | 1.21501665 |
| 54 | MP0005165_increased_susceptibility_to | 1.21178201 |
| 55 | MP0005257_abnormal_intraocular_pressure | 1.20555742 |
| 56 | MP0008004_abnormal_stomach_pH | 1.20346023 |
| 57 | MP0005451_abnormal_body_composition | 1.20335523 |
| 58 | MP0005464_abnormal_platelet_physiology | 1.19270150 |
| 59 | MP0004808_abnormal_hematopoietic_stem | 1.19142620 |
| 60 | MP0005503_abnormal_tendon_morphology | 1.18317121 |
| 61 | MP0002006_tumorigenesis | 1.16198217 |
| 62 | MP0010155_abnormal_intestine_physiology | 1.14730312 |
| 63 | MP0002398_abnormal_bone_marrow | 1.13062462 |
| 64 | MP0001853_heart_inflammation | 1.12452176 |
| 65 | MP0003091_abnormal_cell_migration | 1.12402069 |
| 66 | MP0010368_abnormal_lymphatic_system | 1.11887834 |
| 67 | MP0010307_abnormal_tumor_latency | 1.10364325 |
| 68 | MP0000490_abnormal_crypts_of | 1.08829813 |
| 69 | MP0008007_abnormal_cellular_replicative | 1.08613645 |
| 70 | MP0005164_abnormal_response_to | 1.08424253 |
| 71 | MP0000716_abnormal_immune_system | 1.07754276 |
| 72 | MP0003763_abnormal_thymus_physiology | 1.07079852 |
| 73 | MP0001845_abnormal_inflammatory_respons | 1.06591464 |
| 74 | MP0003828_pulmonary_edema | 1.06103075 |
| 75 | MP0003191_abnormal_cellular_cholesterol | 1.04429845 |
| 76 | MP0000689_abnormal_spleen_morphology | 1.01567946 |
| 77 | MP0002722_abnormal_immune_system | 1.01167862 |
| 78 | MP0009384_cardiac_valve_regurgitation | 1.00674332 |
| 79 | MP0005390_skeleton_phenotype | 1.00169713 |
| 80 | MP0002060_abnormal_skin_morphology | 0.99796450 |
| 81 | MP0000733_abnormal_muscle_development | 0.99173470 |
| 82 | MP0002429_abnormal_blood_cell | 0.98999930 |
| 83 | MP0004883_abnormal_blood_vessel | 0.98790508 |
| 84 | MP0003453_abnormal_keratinocyte_physiol | 0.98746100 |
| 85 | MP0009840_abnormal_foam_cell | 0.98538867 |
| 86 | MP0001243_abnormal_dermal_layer | 0.97982430 |
| 87 | MP0000767_abnormal_smooth_muscle | 0.97480668 |
| 88 | MP0004957_abnormal_blastocyst_morpholog | 0.95244556 |
| 89 | MP0002998_abnormal_bone_remodeling | 0.94453531 |
| 90 | MP0003186_abnormal_redox_activity | 0.92570218 |
| 91 | MP0005621_abnormal_cell_physiology | 0.92111325 |
| 92 | MP0005166_decreased_susceptibility_to | 0.91956273 |
| 93 | MP0003183_abnormal_peptide_metabolism | 0.88541649 |
| 94 | MP0003693_abnormal_embryo_hatching | 0.88191261 |
| 95 | MP0000015_abnormal_ear_pigmentation | 0.87924677 |
| 96 | MP0003795_abnormal_bone_structure | 0.86812470 |
| 97 | MP0002132_abnormal_respiratory_system | 0.83754404 |
| 98 | MP0009763_increased_sensitivity_to | 0.83658850 |
| 99 | MP0001851_eye_inflammation | 0.83237753 |
| 100 | MP0001915_intracranial_hemorrhage | 0.83063718 |
| 101 | MP0003077_abnormal_cell_cycle | 0.81978717 |
| 102 | MP0001873_stomach_inflammation | 0.81906498 |
| 103 | MP0004185_abnormal_adipocyte_glucose | 0.81718822 |
| 104 | MP0002138_abnormal_hepatobiliary_system | 0.80185662 |
| 105 | MP0004510_myositis | 0.79050687 |
| 106 | MP0005623_abnormal_meninges_morphology | 0.78735903 |
| 107 | MP0009053_abnormal_anal_canal | 0.78341199 |
| 108 | MP0000249_abnormal_blood_vessel | 0.75322553 |
| 109 | MP0008469_abnormal_protein_level | 0.75281709 |
| 110 | MP0002019_abnormal_tumor_incidence | 0.74593948 |
| 111 | MP0001730_embryonic_growth_arrest | 0.74258635 |
| 112 | MP0001542_abnormal_bone_strength | 0.74251393 |
| 113 | MP0000383_abnormal_hair_follicle | 0.73947122 |
| 114 | MP0003950_abnormal_plasma_membrane | 0.73761486 |
| 115 | MP0000703_abnormal_thymus_morphology | 0.72695305 |
| 116 | MP0000350_abnormal_cell_proliferation | 0.71261666 |
| 117 | MP0003567_abnormal_fetal_cardiomyocyte | 0.70844048 |
| 118 | MP0001849_ear_inflammation | 0.70664246 |
| 119 | MP0005508_abnormal_skeleton_morphology | 0.70218924 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Protrusio acetabuli (HP:0003179) | 3.57408862 |
| 2 | Eczematoid dermatitis (HP:0000976) | 3.53259354 |
| 3 | Premature rupture of membranes (HP:0001788) | 3.50535458 |
| 4 | Recurrent abscess formation (HP:0002722) | 3.37132961 |
| 5 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 3.15645926 |
| 6 | Osteolytic defects of the hand bones (HP:0009699) | 3.15645926 |
| 7 | Cervical subluxation (HP:0003308) | 2.93540194 |
| 8 | Ankle contracture (HP:0006466) | 2.85486163 |
| 9 | Loss of speech (HP:0002371) | 2.83176944 |
| 10 | Cerebral aneurysm (HP:0004944) | 2.81033909 |
| 11 | Aortic dissection (HP:0002647) | 2.80028632 |
| 12 | Interstitial pulmonary disease (HP:0006530) | 2.80005214 |
| 13 | Vacuolated lymphocytes (HP:0001922) | 2.76551547 |
| 14 | Recurrent bacterial skin infections (HP:0005406) | 2.76220301 |
| 15 | Aortic aneurysm (HP:0004942) | 2.69075660 |
| 16 | Hepatosplenomegaly (HP:0001433) | 2.69050018 |
| 17 | Hematochezia (HP:0002573) | 2.68810793 |
| 18 | Prolonged bleeding time (HP:0003010) | 2.65318741 |
| 19 | Abnormality of macrophages (HP:0004311) | 2.62391449 |
| 20 | Myocardial infarction (HP:0001658) | 2.61896527 |
| 21 | Purpura (HP:0000979) | 2.60615032 |
| 22 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.52412455 |
| 23 | Chronic otitis media (HP:0000389) | 2.50051802 |
| 24 | Spontaneous hematomas (HP:0007420) | 2.49269336 |
| 25 | Cellulitis (HP:0100658) | 2.47955225 |
| 26 | Vertebral compression fractures (HP:0002953) | 2.47482257 |
| 27 | Increased cerebral lipofuscin (HP:0011813) | 2.46915195 |
| 28 | Peritonitis (HP:0002586) | 2.37342049 |
| 29 | Dysostosis multiplex (HP:0000943) | 2.37258988 |
| 30 | Autoimmune thrombocytopenia (HP:0001973) | 2.36256438 |
| 31 | Increased mean platelet volume (HP:0011877) | 2.35963951 |
| 32 | Amyloidosis (HP:0011034) | 2.35336161 |
| 33 | Epistaxis (HP:0000421) | 2.29727598 |
| 34 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.27171027 |
| 35 | Fatigue (HP:0012378) | 2.23690408 |
| 36 | Myositis (HP:0100614) | 2.21212973 |
| 37 | Gingival bleeding (HP:0000225) | 2.17353342 |
| 38 | Recurrent viral infections (HP:0004429) | 2.16446405 |
| 39 | Impaired platelet aggregation (HP:0003540) | 2.14270934 |
| 40 | Abnormal platelet function (HP:0011869) | 2.14270934 |
| 41 | Spondylolisthesis (HP:0003302) | 2.13963512 |
| 42 | Soft skin (HP:0000977) | 2.12512043 |
| 43 | Metaphyseal cupping (HP:0003021) | 2.12234591 |
| 44 | Stomatitis (HP:0010280) | 2.12150927 |
| 45 | Dilatation of the ascending aorta (HP:0005111) | 2.11378948 |
| 46 | Atrophic scars (HP:0001075) | 2.11104581 |
| 47 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.06393745 |
| 48 | Mucopolysacchariduria (HP:0008155) | 2.06393745 |
| 49 | Distal lower limb muscle weakness (HP:0009053) | 2.05606309 |
| 50 | Urticaria (HP:0001025) | 2.02751196 |
| 51 | Upper motor neuron abnormality (HP:0002127) | 2.01362945 |
| 52 | Pustule (HP:0200039) | 2.01323443 |
| 53 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.00994848 |
| 54 | Shallow orbits (HP:0000586) | 2.00806678 |
| 55 | Nonimmune hydrops fetalis (HP:0001790) | 2.00353353 |
| 56 | Ulnar bowing (HP:0003031) | 1.95890543 |
| 57 | Recurrent fungal infections (HP:0002841) | 1.95830869 |
| 58 | Blue sclerae (HP:0000592) | 1.93676133 |
| 59 | Wormian bones (HP:0002645) | 1.91916287 |
| 60 | Progressive neurologic deterioration (HP:0002344) | 1.91715301 |
| 61 | Recurrent cutaneous fungal infections (HP:0011370) | 1.88371890 |
| 62 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.88371890 |
| 63 | IgM deficiency (HP:0002850) | 1.87986553 |
| 64 | Menorrhagia (HP:0000132) | 1.87387540 |
| 65 | Nuclear cataract (HP:0100018) | 1.86061739 |
| 66 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.85685085 |
| 67 | Thoracolumbar scoliosis (HP:0002944) | 1.84240783 |
| 68 | Joint stiffness (HP:0001387) | 1.84151855 |
| 69 | Abnormality of skull ossification (HP:0002703) | 1.83948680 |
| 70 | Amaurosis fugax (HP:0100576) | 1.83532867 |
| 71 | Osteomyelitis (HP:0002754) | 1.82788469 |
| 72 | Increased IgM level (HP:0003496) | 1.82372897 |
| 73 | Vascular tortuosity (HP:0004948) | 1.81989875 |
| 74 | Meningitis (HP:0001287) | 1.80597930 |
| 75 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.80307172 |
| 76 | Recurrent skin infections (HP:0001581) | 1.80136726 |
| 77 | Mucosal telangiectasiae (HP:0100579) | 1.79469108 |
| 78 | Platyspondyly (HP:0000926) | 1.78802798 |
| 79 | Abnormality of the nasal mucosa (HP:0000433) | 1.77990599 |
| 80 | Hypergammaglobulinemia (HP:0010702) | 1.77891697 |
| 81 | Orthostatic hypotension (HP:0001278) | 1.77082282 |
| 82 | Chest pain (HP:0100749) | 1.76775381 |
| 83 | Pulmonary infiltrates (HP:0002113) | 1.76522309 |
| 84 | Genu recurvatum (HP:0002816) | 1.76113532 |
| 85 | Emphysema (HP:0002097) | 1.75589418 |
| 86 | Increased density of long bones (HP:0006392) | 1.75402892 |
| 87 | Disinhibition (HP:0000734) | 1.75386110 |
| 88 | Abnormality of the calcaneus (HP:0008364) | 1.75026890 |
| 89 | Abnormality of T cell physiology (HP:0011840) | 1.74982723 |
| 90 | Thrombocytosis (HP:0001894) | 1.73811406 |
| 91 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.73767041 |
| 92 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.73767041 |
| 93 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.73767041 |
| 94 | Broad face (HP:0000283) | 1.73764434 |
| 95 | Vertebral hypoplasia (HP:0008417) | 1.73517134 |
| 96 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 1.73517134 |
| 97 | Persistence of primary teeth (HP:0006335) | 1.72353850 |
| 98 | Arterial tortuosity (HP:0005116) | 1.71998719 |
| 99 | Skin ulcer (HP:0200042) | 1.71533586 |
| 100 | Abnormality of the peritoneum (HP:0002585) | 1.71501640 |
| 101 | Increased variability in muscle fiber diameter (HP:0003557) | 1.71336531 |
| 102 | Systemic lupus erythematosus (HP:0002725) | 1.71108524 |
| 103 | Increased IgE level (HP:0003212) | 1.70961868 |
| 104 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.70947372 |
| 105 | Recurrent bronchitis (HP:0002837) | 1.70944801 |
| 106 | Abnormal foot bone ossification (HP:0010675) | 1.70625216 |
| 107 | Abnormality of the acetabulum (HP:0003170) | 1.70606430 |
| 108 | Obstructive lung disease (HP:0006536) | 1.70579794 |
| 109 | Chronic obstructive pulmonary disease (HP:0006510) | 1.70579794 |
| 110 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.70228449 |
| 111 | Thin bony cortex (HP:0002753) | 1.69999773 |
| 112 | Beaking of vertebral bodies (HP:0004568) | 1.69514964 |
| 113 | Tetraparesis (HP:0002273) | 1.68722145 |
| 114 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.68608873 |
| 115 | Mediastinal lymphadenopathy (HP:0100721) | 1.67163427 |
| 116 | Bicuspid aortic valve (HP:0001647) | 1.65515978 |
| 117 | Decreased skull ossification (HP:0004331) | 1.65498635 |
| 118 | Vasculitis (HP:0002633) | 1.64993335 |
| 119 | Increased CSF protein (HP:0002922) | 1.64672915 |
| 120 | Short nail (HP:0001799) | 1.63362153 |
| 121 | Hypertensive crisis (HP:0100735) | 1.62776143 |
| 122 | Abnormal vertebral ossification (HP:0100569) | 1.62255206 |
| 123 | Abnormality of T cell number (HP:0011839) | 1.62170349 |
| 124 | Petechiae (HP:0000967) | 1.60136552 |
| 125 | Abnormality of T cells (HP:0002843) | 1.59976752 |
| 126 | Flat acetabular roof (HP:0003180) | 1.58352105 |
| 127 | Poor head control (HP:0002421) | 1.58276159 |
| 128 | Axonal loss (HP:0003447) | 1.58244838 |
| 129 | T lymphocytopenia (HP:0005403) | 1.58179914 |
| 130 | Abnormality of glycolipid metabolism (HP:0010969) | 1.56899530 |
| 131 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.56899530 |
| 132 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.56899530 |
| 133 | Abnormal platelet volume (HP:0011876) | 1.56389995 |
| 134 | Abnormality of the lumbar spine (HP:0100712) | 1.56242488 |
| 135 | Leukocytosis (HP:0001974) | 1.55643273 |
| 136 | Mitral valve prolapse (HP:0001634) | 1.55438021 |
| 137 | Eosinophilia (HP:0001880) | 1.54948744 |
| 138 | Gingivitis (HP:0000230) | 1.54751265 |
| 139 | Camptodactyly of toe (HP:0001836) | 1.54546068 |
| 140 | Syringomyelia (HP:0003396) | 1.54187536 |
| 141 | Spinal cord lesions (HP:0100561) | 1.54187536 |
| 142 | Epiphyseal dysplasia (HP:0002656) | 1.53603863 |
| 143 | Orchitis (HP:0100796) | 1.53272158 |
| 144 | Polycythemia (HP:0001901) | 1.53027903 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 2.62040890 |
| 2 | ERN1 | 2.54068537 |
| 3 | PRPF4B | 2.46900268 |
| 4 | STK10 | 2.46243825 |
| 5 | NME2 | 2.36238266 |
| 6 | MAP4K1 | 2.31314711 |
| 7 | LRRK2 | 2.28607222 |
| 8 | RIPK4 | 2.24962723 |
| 9 | EPHB1 | 2.24039101 |
| 10 | TESK2 | 2.17090899 |
| 11 | TGFBR2 | 1.98700013 |
| 12 | SIK3 | 1.89741624 |
| 13 | MOS | 1.85308228 |
| 14 | BMPR2 | 1.84527561 |
| 15 | SMG1 | 1.78626274 |
| 16 | KDR | 1.78178197 |
| 17 | MST4 | 1.74763801 |
| 18 | PKN2 | 1.71260533 |
| 19 | BLK | 1.68280190 |
| 20 | RPS6KA4 | 1.65730048 |
| 21 | TESK1 | 1.59911133 |
| 22 | PAK4 | 1.59285415 |
| 23 | MAP3K12 | 1.59278693 |
| 24 | JAK3 | 1.56006241 |
| 25 | TBK1 | 1.53473156 |
| 26 | TTN | 1.51304806 |
| 27 | MAP3K10 | 1.48254494 |
| 28 | ZAP70 | 1.47169900 |
| 29 | FLT3 | 1.46501404 |
| 30 | TYK2 | 1.44053100 |
| 31 | MYLK | 1.42038547 |
| 32 | SCYL2 | 1.40056580 |
| 33 | MAP3K13 | 1.38625424 |
| 34 | PIM2 | 1.34439586 |
| 35 | MAP3K3 | 1.32915611 |
| 36 | NEK9 | 1.31131576 |
| 37 | KIT | 1.27253885 |
| 38 | CSK | 1.25889634 |
| 39 | IRAK4 | 1.23558605 |
| 40 | FES | 1.23366226 |
| 41 | MAP2K3 | 1.17242963 |
| 42 | PTK6 | 1.16896907 |
| 43 | EPHA2 | 1.15880060 |
| 44 | CSF1R | 1.15639654 |
| 45 | LIMK1 | 1.15054744 |
| 46 | BRSK2 | 1.13621355 |
| 47 | VRK2 | 1.12795853 |
| 48 | ARAF | 1.10501881 |
| 49 | MAP3K8 | 1.09881026 |
| 50 | MAP3K14 | 1.09017227 |
| 51 | EEF2K | 1.05872023 |
| 52 | BTK | 1.05720171 |
| 53 | TGFBR1 | 1.04513377 |
| 54 | WEE1 | 1.04037192 |
| 55 | TRPM7 | 1.03547912 |
| 56 | FGR | 1.03077546 |
| 57 | YES1 | 1.02531662 |
| 58 | EPHA3 | 1.02354374 |
| 59 | ITK | 1.01284185 |
| 60 | CLK1 | 0.97121892 |
| 61 | PIM1 | 0.96491162 |
| 62 | IKBKB | 0.93499253 |
| 63 | TEC | 0.91425407 |
| 64 | PASK | 0.91086970 |
| 65 | CDK6 | 0.91001802 |
| 66 | PIK3CG | 0.90266652 |
| 67 | FGFR4 | 0.90083022 |
| 68 | ILK | 0.89730310 |
| 69 | KSR2 | 0.89302089 |
| 70 | BUB1 | 0.88727370 |
| 71 | JAK1 | 0.87829336 |
| 72 | IRAK3 | 0.87598035 |
| 73 | SIK1 | 0.87506127 |
| 74 | STK4 | 0.87493156 |
| 75 | STK3 | 0.86963584 |
| 76 | PAK2 | 0.86528855 |
| 77 | EIF2AK1 | 0.86409053 |
| 78 | MET | 0.84453625 |
| 79 | RPS6KB2 | 0.81794198 |
| 80 | MAP3K1 | 0.81686313 |
| 81 | PDGFRA | 0.78618806 |
| 82 | NLK | 0.78592270 |
| 83 | PBK | 0.75303159 |
| 84 | TIE1 | 0.74542792 |
| 85 | NEK2 | 0.73394830 |
| 86 | PDK2 | 0.72092622 |
| 87 | CHUK | 0.71591543 |
| 88 | NEK1 | 0.70796672 |
| 89 | PRKG2 | 0.70303555 |
| 90 | DDR2 | 0.69741824 |
| 91 | MAPKAPK2 | 0.69299236 |
| 92 | MARK3 | 0.69033193 |
| 93 | MAP2K2 | 0.68439120 |
| 94 | PTK2 | 0.68295521 |
| 95 | BMX | 0.67941612 |
| 96 | EIF2AK3 | 0.67350879 |
| 97 | MAP3K11 | 0.65654121 |
| 98 | IKBKE | 0.64266720 |
| 99 | LCK | 0.64076073 |
| 100 | TXK | 0.64055835 |
| 101 | MAPKAPK3 | 0.63441178 |
| 102 | CDK12 | 0.63170524 |
| 103 | ERBB4 | 0.61799152 |
| 104 | LATS1 | 0.61796470 |
| 105 | HCK | 0.60888956 |
| 106 | SYK | 0.59831171 |
| 107 | DYRK1B | 0.58063971 |
| 108 | ROCK2 | 0.56928135 |
| 109 | DMPK | 0.56411589 |
| 110 | GRK6 | 0.56114470 |
| 111 | ABL2 | 0.56027671 |
| 112 | RIPK1 | 0.55918233 |
| 113 | FGFR3 | 0.55135400 |
| 114 | CDK4 | 0.55062718 |
| 115 | PDGFRB | 0.53783226 |
| 116 | STK24 | 0.53733192 |
| 117 | TAOK3 | 0.53063042 |
| 118 | CAMK1D | 0.52887734 |
| 119 | RAF1 | 0.52471331 |
| 120 | MAP3K5 | 0.52441123 |
| 121 | TAOK1 | 0.50252011 |
| 122 | ALK | 0.48337168 |
| 123 | LYN | 0.48176525 |
| 124 | JAK2 | 0.48140337 |
| 125 | ACVR1B | 0.47273657 |
| 126 | CDK7 | 0.45735756 |
| 127 | CDK9 | 0.43138191 |
| 128 | GSK3A | 0.42862506 |
| 129 | TAOK2 | 0.42096497 |
| 130 | PAK1 | 0.42018474 |
| 131 | TRIM28 | 0.41462782 |
| 132 | MELK | 0.38706705 |
| 133 | FER | 0.38137968 |
| 134 | CDC42BPA | 0.37663642 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.16861270 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 2.14253530 |
| 3 | * Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.85799186 |
| 4 | Lysosome_Homo sapiens_hsa04142 | 1.79727859 |
| 5 | Shigellosis_Homo sapiens_hsa05131 | 1.78837174 |
| 6 | * Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.78182698 |
| 7 | * Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.68042648 |
| 8 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.67254509 |
| 9 | Legionellosis_Homo sapiens_hsa05134 | 1.65331828 |
| 10 | DNA replication_Homo sapiens_hsa03030 | 1.64822878 |
| 11 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.64142245 |
| 12 | Malaria_Homo sapiens_hsa05144 | 1.62995806 |
| 13 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.53712199 |
| 14 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.50471532 |
| 15 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.50130824 |
| 16 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.49865113 |
| 17 | Viral myocarditis_Homo sapiens_hsa05416 | 1.46819583 |
| 18 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.45177692 |
| 19 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.44196994 |
| 20 | Other glycan degradation_Homo sapiens_hsa00511 | 1.42219557 |
| 21 | Measles_Homo sapiens_hsa05162 | 1.40177413 |
| 22 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.39065421 |
| 23 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.37691712 |
| 24 | Apoptosis_Homo sapiens_hsa04210 | 1.37684887 |
| 25 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.36502654 |
| 26 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.35767439 |
| 27 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.30732819 |
| 28 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.30210049 |
| 29 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.29025089 |
| 30 | Protein export_Homo sapiens_hsa03060 | 1.28884350 |
| 31 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.28218406 |
| 32 | * Focal adhesion_Homo sapiens_hsa04510 | 1.28031545 |
| 33 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.24869871 |
| 34 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.23905134 |
| 35 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.20359414 |
| 36 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.19760929 |
| 37 | * Pertussis_Homo sapiens_hsa05133 | 1.17902380 |
| 38 | * Adherens junction_Homo sapiens_hsa04520 | 1.17606070 |
| 39 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.16623593 |
| 40 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.15963976 |
| 41 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.14464486 |
| 42 | Salmonella infection_Homo sapiens_hsa05132 | 1.10364085 |
| 43 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.10179682 |
| 44 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.09032340 |
| 45 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.08980289 |
| 46 | Cell cycle_Homo sapiens_hsa04110 | 1.05715057 |
| 47 | * Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.05104843 |
| 48 | * Viral carcinogenesis_Homo sapiens_hsa05203 | 1.04853616 |
| 49 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.04519946 |
| 50 | Hepatitis B_Homo sapiens_hsa05161 | 1.03991795 |
| 51 | Galactose metabolism_Homo sapiens_hsa00052 | 1.01468609 |
| 52 | * Tuberculosis_Homo sapiens_hsa05152 | 1.00949347 |
| 53 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.00340676 |
| 54 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.00030634 |
| 55 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.99277631 |
| 56 | Proteasome_Homo sapiens_hsa03050 | 0.99091181 |
| 57 | Amoebiasis_Homo sapiens_hsa05146 | 0.97944136 |
| 58 | Ribosome_Homo sapiens_hsa03010 | 0.96784189 |
| 59 | Phagosome_Homo sapiens_hsa04145 | 0.96213262 |
| 60 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.95852476 |
| 61 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.94207686 |
| 62 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.94135643 |
| 63 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.93936322 |
| 64 | HTLV-I infection_Homo sapiens_hsa05166 | 0.92961498 |
| 65 | Base excision repair_Homo sapiens_hsa03410 | 0.92423429 |
| 66 | Influenza A_Homo sapiens_hsa05164 | 0.92300554 |
| 67 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.90065152 |
| 68 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.88946072 |
| 69 | Mismatch repair_Homo sapiens_hsa03430 | 0.88164362 |
| 70 | * MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.87872882 |
| 71 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.87732735 |
| 72 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.87584745 |
| 73 | * Platelet activation_Homo sapiens_hsa04611 | 0.85773000 |
| 74 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.85631532 |
| 75 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.85348179 |
| 76 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.82668005 |
| 77 | Spliceosome_Homo sapiens_hsa03040 | 0.81022839 |
| 78 | * Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.80991305 |
| 79 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.80861942 |
| 80 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.80208841 |
| 81 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.79768203 |
| 82 | Thyroid cancer_Homo sapiens_hsa05216 | 0.78534045 |
| 83 | Allograft rejection_Homo sapiens_hsa05330 | 0.77161544 |
| 84 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.77030463 |
| 85 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.76598325 |
| 86 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.74842078 |
| 87 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.73159213 |
| 88 | Bladder cancer_Homo sapiens_hsa05219 | 0.72459004 |
| 89 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.71230666 |
| 90 | * Endocytosis_Homo sapiens_hsa04144 | 0.69869562 |
| 91 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.68916909 |
| 92 | Prostate cancer_Homo sapiens_hsa05215 | 0.68784014 |
| 93 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.68108453 |
| 94 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.67722566 |
| 95 | * Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.67440861 |
| 96 | * T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.64993200 |
| 97 | Hepatitis C_Homo sapiens_hsa05160 | 0.64964592 |
| 98 | Carbon metabolism_Homo sapiens_hsa01200 | 0.63799417 |
| 99 | * Pathways in cancer_Homo sapiens_hsa05200 | 0.62576621 |
| 100 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.62494443 |
| 101 | RNA transport_Homo sapiens_hsa03013 | 0.61937742 |
| 102 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.58425888 |
| 103 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.57923444 |
| 104 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.57636558 |
| 105 | Endometrial cancer_Homo sapiens_hsa05213 | 0.56492384 |
| 106 | * Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.56258989 |
| 107 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.56060071 |
| 108 | * TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.55652494 |
| 109 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.55505371 |
| 110 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.54762467 |
| 111 | Asthma_Homo sapiens_hsa05310 | 0.53078018 |
| 112 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.52564049 |
| 113 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.52415994 |
| 114 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.51086917 |
| 115 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.49491056 |
| 116 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.49300791 |
| 117 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.48419889 |
| 118 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.48019233 |
| 119 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.47964253 |
| 120 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.46269415 |
| 121 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.46159827 |

